Therasense Inc
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision … Read more
Therasense Inc (THER) - Total Liabilities
Latest total liabilities as of December 2023: $40.97 Million USD
Based on the latest financial reports, Therasense Inc (THER) has total liabilities worth $40.97 Million USD as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Therasense Inc - Total Liabilities Trend (2007–2023)
This chart illustrates how Therasense Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Therasense Inc Competitors by Total Liabilities
The table below lists competitors of Therasense Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Unieuro SpA
STU:1UI
|
Germany | €1.36 Billion |
|
Eco Innovation Group Inc
PINK:ECOX
|
USA | $3.87 Million |
|
ALMIRALL (E2Z.SG)
STU:E2Z
|
Germany | €834.81 Million |
|
RAMSAY GENERALE (GD6.SG)
STU:GD6
|
Germany | €5.67 Billion |
|
First Tidal Acquisition Corp.
V:AAA-P
|
Canada | CA$3.43K |
|
NORDIC SEMICONDUCTO
BE:N0S
|
Germany | €257.83 Million |
Liability Composition Analysis (2007–2023)
This chart breaks down Therasense Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 14.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Therasense Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Therasense Inc (2007–2023)
The table below shows the annual total liabilities of Therasense Inc from 2007 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-09-30 | $40.97 Million | +540.09% |
| 2022-09-30 | $6.40 Million | +78.57% |
| 2021-09-30 | $3.58 Million | +138.33% |
| 2020-09-30 | $1.50 Million | -90.62% |
| 2019-09-30 | $16.03 Million | +8.06% |
| 2018-09-30 | $14.84 Million | +1578.40% |
| 2017-09-30 | $883.95K | +416.15% |
| 2016-09-30 | $171.26K | -28.52% |
| 2014-09-30 | $239.58K | -66.91% |
| 2013-09-30 | $724.11K | -17.99% |
| 2012-09-30 | $882.96K | +56.44% |
| 2011-09-30 | $564.42K | +885.43% |
| 2010-09-30 | $57.28K | +525.09% |
| 2009-09-30 | $9.16K | -83.74% |
| 2008-09-30 | $56.36K | +91.28% |
| 2007-09-30 | $29.46K | -- |